Hung-Yu Chan Selected Research

Hung-Yu Chan Research Topics

Disease

20	Schizophrenia (Dementia Praecox) 09/2022 - 06/2006
5	Psychotic Disorders (Schizoaffective Disorder) 03/2022 - 01/2007
3	Mental Disorders (Mental Disorder) 01/2022 - 02/2007
3	Dementia (Dementias) 01/2022 - 01/2014
3	Tardive Dyskinesia 01/2018 - 09/2010
2	Mania (Manias) 01/2021 - 04/2010
2	Hyperprolactinemia 11/2020 - 12/2013
2	Treatment-Resistant Schizophrenia 10/2020 - 12/2019
2	Hyperuricemia 12/2013 - 04/2010
2	Parkinsonian Disorders (Parkinsonism) 08/2013 - 04/2010
2	Depressive Disorder (Melancholia) 05/2013 - 02/2007
2	Anxiety Disorders (Anxiety Disorder) 09/2012 - 05/2006
1	Diabetes Mellitus 09/2022
1	Neurotic Disorders (Neuroses) 01/2022
1	Hallucinations (Hallucination) 01/2022
1	Catastrophic Illness 01/2022
1	Hashimoto's encephalitis 12/2021
1	Constipation 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Infections 12/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2020
1	Pneumonia (Pneumonitis) 09/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Body Weight (Weight, Body) 12/2015
1	Pain (Aches) 04/2015
1	Chronic Pain 04/2015
1	Edema (Dropsy) 10/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2014
1	Pathologic Complete Response 02/2014
1	Adjustment Disorders (Adjustment Disorder) 09/2012
1	Mood Disorders (Mood Disorder) 09/2012
1	Psychomotor Agitation (Akathisia) 04/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2010
1	Weight Gain 01/2007
1	Substance-Related Disorders (Drug Abuse) 05/2006
1	Thymoma (Thymic Carcinoma) 02/2006

Drug/Important Bio-Agent (IBA)

19	Antipsychotic Agents (Antipsychotics)IBA 09/2022 - 04/2010
6	Aripiprazole (Abilify)FDA Link 01/2022 - 01/2007
4	Risperidone (Risperdal Consta)FDA LinkGeneric 03/2022 - 01/2007
4	ProlactinIBA 11/2020 - 01/2007
4	Antidepressive Agents (Antidepressants)IBA 04/2015 - 09/2012
3	Clozapine (Clozaril)FDA LinkGeneric 10/2020 - 01/2018
3	Haloperidol (Haldol)FDA LinkGeneric 02/2017 - 04/2010
2	LaxativesIBA 09/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 12/2020 - 02/2007
2	BenzodiazepinesIBA 07/2020 - 08/2013
2	Olanzapine (Zyprexa)FDA Link 06/2014 - 09/2010
2	zotepineIBA 12/2013 - 04/2010
2	Heroin (Diamorphine)IBA 02/2007 - 05/2006
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 12/2021
1	AntibodiesIBA 12/2021
1	SteroidsIBA 12/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Carbon MonoxideIBA 03/2020
1	Nicotine FDA Link 03/2020
1	Sulpiride (neogama)IBA 02/2017
1	Triglycerides (Triacylglycerol)IBA 12/2015
1	CholesterolIBA 12/2015
1	Quetiapine Fumarate (Seroquel)FDA Link 10/2014
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 07/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2014
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	Uric Acid (Urate)IBA 12/2013
1	LithiumIBA 04/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2006
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 10/2006
1	GTP-Binding Proteins (G-Protein)IBA 06/2006
1	Illicit Drugs (Recreational Drugs)IBA 05/2006
1	Protein Isoforms (Isoforms)IBA 02/2006
1	Protein Kinases (Protein Kinase)IBA 02/2006

Therapy/Procedure

5	Patient Readmission 03/2022 - 01/2019
4	Injections 01/2022 - 01/2019
2	Therapeutics 12/2021 - 01/2021
1	Inappropriate Prescribing 07/2020
1	Polypharmacy 07/2020
1	Nebulizers and Vaporizers (Inhaler) 03/2020